Clover Health Investments, Corp. - Class A Common stock (CLOV)

Even during a down period for the markets, Clover Health has gone against the grain, climbing to $3.82. Its shares have yielded a 26.1% return over the last six months, beating the S&P 500 by 27.7%. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.

Let’s dig into the relative performance of Clover Health (NASDAQ:CLOV) and its peers as we unravel the now-completed Q4 health insurance providers earnings season.

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers industry, including Centene (NYSE:CNC) and its peers.

Let’s dig into the relative performance of Cigna (NYSE:CI) and its peers as we unravel the now-completed Q4 health insurance providers earnings season.

Stocks had another down week despite a mostly benign jobs report; and with the latest reads on inflation coming next week the uncertainty may continue

After a steep decline from its all-time high prices, shares of Hims & Hers are now recovering to show investor interest in the space.

Stocks recovered on Friday, with all three major indexes in the green, as the tech sector bounced back from Thursday's losses with NVIDIA Corp. (NASDAQ:NVDA) up 1.37% and Tesla, Inc. (NASDAQ:TSLA)

Health insurance company Clover Health (NASDAQ:CLOV) missed Wall Street’s revenue expectations in Q4 CY2024, with sales falling 34% year on year to $337 million. Its GAAP loss of $0.04 per share was $0.03 above analysts’ consensus estimates.

The S&P 500 and Nasdaq both slipped into the red, reversing early gains on Thursday, while the Dow Jones remained in positive territory in midday trading.

Health insurance company Clover Health (NASDAQ:CLOV) will be reporting results tomorrow afternoon. Here’s what to look for.

Cramer says people believe AMD "will not be able to deliver on this quarter" and so he's reluctant to get in.

Here are a variety of lesser-known charts from my “Recents” watch list. Quite a few of them look like good bullish plays.

Trump's second term could bring significant changes to U.S. healthcare, with cuts to ACA subsidies and potential Medicare privatization.

AbbVie Inc., which split from Abbott Laboratories remains more than a decade ago, is doing "very, very well," Jim Cramer says.

Clover Health Investments shares are trading higher by 4.6% Friday afternoon. The company announced that CMS raised its PPO Medicare Advantage plans' Star rating to 4 Stars for 2025.

U.S. indices closed Wednesday in positive territory, with the Dow Jones Industrial Average increasing by 0.09% to 42,196.52.

Clover Health Investments shares are trading higher Wednesday amid increased trading volume and gaining traction across social media platforms. Here's what you need to know.